Back to mobile site
Get it on Google Play

BriaCell reports extended survival in metastatic breast cancer trial

January 27, 2026 7:30 AM EST Send to a Friend
BriaCell Therapeutics Corp. (NASDAQ: BCTX, BCTXW, BCTXZ, BCTXL) (TSX: BCT) announced that 9 of 25 patients treated with its Bria-IMT ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login